Sees FY25 revenue $5.7B-$6.1B, consensus $5.82B
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EW:
- Edwards Lifesciences reports Q1 EPS 61c, consensus 60c
- Notable companies reporting after market close
- Is EW a Buy, Before Earnings?
- Edwards says eight-year data confirm long-term durability of Resilia tissue
- Hold Rating Maintained for Edwards Lifesciences Amidst Positive Developments in Mitral Valve Approval and TAVR Challenges